The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Sun Anthony Y since 2014.
This trader's CIK number is 1377952.
At the time of last reporting, Sun Anthony Y was the President & CEO of Zentalis Pharmaceuticals, Inc.. (stock ticker symbol ZNTL).
Also see all insider trading activities at Zentalis Pharmaceuticals, Inc..
Insider Buying | Insider Sales | Option Exercises | |||||
---|---|---|---|---|---|---|---|
Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
2022 | ZNTL | 0 | $0 | 88,501 | $5,230,780 | 0 | $0 |
2021 | ZNTL | 0 | $0 | 390,446 | $21,095,448 | 0 | $0 |
2020 | ZNTL | 888 | $15,984 | 128,963 | $6,537,304 | 0 | $0 |
Insider Buying | Insider Sales | Option Exercises | |||||
---|---|---|---|---|---|---|---|
Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
2015 | VSAR | 145,000 | $2,501,250 | 0 | $0 | 0 | $0 |
2014 | VSAR | 60,000 | $1,260,000 | 0 | $0 | 0 | $0 |
1. Zentalis Pharmaceuticals, Inc. (ZNTL)
Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
---|---|---|---|---|---|
2022-04-04 | ZNTL | Sale | 10,471 | 48.50 | 507,843 |
2022-04-05 | ZNTL | Sale | 10,471 | 51.72 | 541,591 |
2022-03-02 | ZNTL | Sale | 10,471 | 50.51 | 528,911 |
2022-03-01 | ZNTL | Sale | 10,471 | 49.90 | 522,471 |
2022-02-14 | ZNTL | Sale | 4,733 | 50.46 | 238,808 |
2022-02-01 | ZNTL | Sale | 10,471 | 58.08 | 608,197 |
2022-02-02 | ZNTL | Sale | 10,471 | 58.08 | 608,176 |
2022-01-04 | ZNTL | Sale | 10,471 | 79.11 | 828,360 |
2022-01-03 | ZNTL | Sale | 10,471 | 80.83 | 846,423 |
2021-12-01 | ZNTL | Sale | 10,471 | 77.53 | 811,795 |
2021-12-02 | ZNTL | Sale | 10,471 | 75.89 | 794,644 |
2021-11-01 | ZNTL | Sale | 10,471 | 81.97 | 858,276 |
2021-11-02 | ZNTL | Sale | 10,471 | 80.27 | 840,528 |
2021-10-04 | ZNTL | Sale | 26,799 | 66.56 | 1,783,768 |
2021-09-01 | ZNTL | Sale | 26,794 | 67.83 | 1,817,490 |
2021-08-02 | ZNTL | Sale | 19,015 | 51.69 | 982,790 |
2021-08-03 | ZNTL | Sale | 7,779 | 50.69 | 394,333 |
2021-07-06 | ZNTL | Sale | 25,045 | 47.59 | 1,192,016 |
2021-07-07 | ZNTL | Sale | 17,804 | 47.04 | 837,500 |
2021-07-01 | ZNTL | Sale | 26,794 | 51.71 | 1,385,544 |
2021-06-01 | ZNTL | Sale | 26,794 | 54.33 | 1,455,771 |
2021-05-03 | ZNTL | Sale | 26,794 | 58.63 | 1,570,825 |
2021-04-05 | ZNTL | Sale | 64,562 | 44.22 | 2,854,931 |
2021-03-01 | ZNTL | Sale | 26,794 | 41.52 | 1,112,620 |
2021-02-01 | ZNTL | Sale | 26,794 | 37.82 | 1,013,295 |
2021-01-04 | ZNTL | Sale | 26,794 | 51.85 | 1,389,322 |
2020-12-07 | ZNTL | Sale | 35,606 | 52.87 | 1,882,346 |
2020-12-04 | ZNTL | Sale | 39,769 | 50.97 | 2,026,946 |
2020-12-02 | ZNTL | Sale | 26,794 | 51.26 | 1,373,567 |
2020-04-07 | ZNTL | Buy | 888 | 18.00 | 15,984 |
2020-11-23 | ZNTL | Sale | 15,408 | 46.82 | 721,387 |
2020-11-24 | ZNTL | Sale | 11,386 | 46.82 | 533,058 |
Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
---|---|---|---|---|---|
2015-01-27 | VSAR | Buy | 145,000 | 17.25 | 2,501,250 |
2014-03-26 | VSAR | Buy | 60,000 | 21.00 | 1,260,000 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Sun Anthony Y (President & CEO of Zentalis Pharmaceuticals, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.